Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

• Status: Completed
• Trial end date: 2018-11-06
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to demonstrate that induction chemotherapy followed by radiation therapy plus Cetuximab will give better results than the validated treatment (chemoradiotherapy), for treatment of locoregional advanced head and neck cancers.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
• Treatments: Carboplatin; Cetuximab; Fluorouracil

Criteria

Inclusion Criteria:

• head and neck locally advanced,non metastatic carcinoma

• not suitable for surgery

Exclusion Criteria:

• non squamous cell head and neck cancer

• previous malignancy

• previous treatment